Axsome Therapeutics(MX:AXSM)
MX$1,519.000.00 (0.00%)
MX:AXSM
Axsome Therapeutics earnings date
MX$1,519.00
At close:0.00 (0.00%)
Axsome Therapeutics (AXSM) Q3 2023 Earnings Report
1 Followers
MX:AXSM Q3 2023 EPS Results
- Actual EPS
- -MXN 24.55
- Consensus EPS
- -MXN 22.38
- Beat/Miss
- Missed by -MXN 2.18
- One Year Ago EPS
- -MXN 19.90
MX:AXSM Q3 2023 Revenue Results
- Actual Revenue
- MXN 1.07B
- Expected Revenue
- MXN 1.02B
- Beat/Miss
- Beat by +MXN 54.40M
- YoY Revenue Growth
- +243.08%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/06/2023
- Time
- Before Open
- Conference Call
- Monday, November 6, 2023
MX:AXSM Upcoming Earnings
Axsome Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
MX:AXSM Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:AXSM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.89- | -10.42 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -11.79-4.65 | -17.48 | 73.40% (+12.83) | |
| Aug 10, 2026 | 2026 (Q2) | -16.59-18.41 | -18.04 | -2.06% (-0.37) | |
| May 04, 2026 | 2026 (Q1) | -15.70-23.44 | -22.69 | -3.28% (-0.74) | |
| Feb 23, 2026 | 2025 (Q4) | -12.91-10.42 | -28.64 | 63.64% (+18.23) | |
| Nov 03, 2025 | 2025 (Q3) | -16.01-17.48 | -24.92 | 29.85% (+7.44) | |
| Aug 04, 2025 | 2025 (Q2) | -19.62-18.04 | -31.06 | 41.92% (+13.02) | |
| May 05, 2025 | 2025 (Q1) | -25.13-22.69 | -26.78 | 15.28% (+4.09) | |
| Feb 18, 2025 | 2024 (Q4) | -18.62-28.64 | -38.69 | 25.96% (+10.04) | |
| Nov 12, 2024 | 2024 (Q3) | -25.72-24.92 | -24.55 | -1.52% (-0.37) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
